| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |